Cargando…
Understanding DNA Damage Response and DNA Repair in Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma (MM), a malignant plasma cell disorder, is characterized by abnormal DNA damage response (DDR). MM cells adapt over time via gene mutations or chromosomal aberrations, including changes to DDR and DNA repair genes. Increased DNA repair and avoidance of DNA-damaged in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453069/ https://www.ncbi.nlm.nih.gov/pubmed/37627183 http://dx.doi.org/10.3390/cancers15164155 |
_version_ | 1785095830802268160 |
---|---|
author | Petrilla, Cole Galloway, Joshua Kudalkar, Ruchi Ismael, Aya Cottini, Francesca |
author_facet | Petrilla, Cole Galloway, Joshua Kudalkar, Ruchi Ismael, Aya Cottini, Francesca |
author_sort | Petrilla, Cole |
collection | PubMed |
description | SIMPLE SUMMARY: Multiple myeloma (MM), a malignant plasma cell disorder, is characterized by abnormal DNA damage response (DDR). MM cells adapt over time via gene mutations or chromosomal aberrations, including changes to DDR and DNA repair genes. Increased DNA repair and avoidance of DNA-damaged induced cellular death promote tumor formation, progression, and resistance to treatments. Because of the wide array of DDR and DNA repair mechanisms, DDR is an elusive target. Currently, treatments such as proteasome inhibitors and alkylating agents are commonly used in patients with MM. These treatments affect DDR and DNA repair pathways in different ways. As more studies are conducted, targeting DDR mechanisms might emerge as new treatments, as described in this review. ABSTRACT: Multiple myeloma (MM) is a plasma cell malignancy characterized by several genetic abnormalities, including chromosomal translocations, genomic deletions and gains, and point mutations. DNA damage response (DDR) and DNA repair mechanisms are altered in MM to allow for tumor development, progression, and resistance to therapies. Damaged DNA rarely induces an apoptotic response, given the presence of ataxia-telangiectasia mutated (ATM) loss-of-function or mutations, as well as deletions, mutations, or downregulation of tumor protein p53 (TP53) and tumor protein p73 (TP73). Moreover, DNA repair mechanisms are either hyperactive or defective to allow for rapid correction of the damage or permissive survival. Medications used to treat patients with MM can induce DNA damage, by either direct effects (mono-adducts induced by melphalan), or as a result of reactive oxygen species (ROS) production by proteasome inhibitors such as bortezomib. In this review, we will describe the mechanisms of DDR and DNA repair in normal tissues, the contribution of these pathways to MM disease progression and other phenotypes, and the potential therapeutic opportunities for patients with MM. |
format | Online Article Text |
id | pubmed-10453069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104530692023-08-26 Understanding DNA Damage Response and DNA Repair in Multiple Myeloma Petrilla, Cole Galloway, Joshua Kudalkar, Ruchi Ismael, Aya Cottini, Francesca Cancers (Basel) Review SIMPLE SUMMARY: Multiple myeloma (MM), a malignant plasma cell disorder, is characterized by abnormal DNA damage response (DDR). MM cells adapt over time via gene mutations or chromosomal aberrations, including changes to DDR and DNA repair genes. Increased DNA repair and avoidance of DNA-damaged induced cellular death promote tumor formation, progression, and resistance to treatments. Because of the wide array of DDR and DNA repair mechanisms, DDR is an elusive target. Currently, treatments such as proteasome inhibitors and alkylating agents are commonly used in patients with MM. These treatments affect DDR and DNA repair pathways in different ways. As more studies are conducted, targeting DDR mechanisms might emerge as new treatments, as described in this review. ABSTRACT: Multiple myeloma (MM) is a plasma cell malignancy characterized by several genetic abnormalities, including chromosomal translocations, genomic deletions and gains, and point mutations. DNA damage response (DDR) and DNA repair mechanisms are altered in MM to allow for tumor development, progression, and resistance to therapies. Damaged DNA rarely induces an apoptotic response, given the presence of ataxia-telangiectasia mutated (ATM) loss-of-function or mutations, as well as deletions, mutations, or downregulation of tumor protein p53 (TP53) and tumor protein p73 (TP73). Moreover, DNA repair mechanisms are either hyperactive or defective to allow for rapid correction of the damage or permissive survival. Medications used to treat patients with MM can induce DNA damage, by either direct effects (mono-adducts induced by melphalan), or as a result of reactive oxygen species (ROS) production by proteasome inhibitors such as bortezomib. In this review, we will describe the mechanisms of DDR and DNA repair in normal tissues, the contribution of these pathways to MM disease progression and other phenotypes, and the potential therapeutic opportunities for patients with MM. MDPI 2023-08-17 /pmc/articles/PMC10453069/ /pubmed/37627183 http://dx.doi.org/10.3390/cancers15164155 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Petrilla, Cole Galloway, Joshua Kudalkar, Ruchi Ismael, Aya Cottini, Francesca Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title | Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title_full | Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title_fullStr | Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title_full_unstemmed | Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title_short | Understanding DNA Damage Response and DNA Repair in Multiple Myeloma |
title_sort | understanding dna damage response and dna repair in multiple myeloma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453069/ https://www.ncbi.nlm.nih.gov/pubmed/37627183 http://dx.doi.org/10.3390/cancers15164155 |
work_keys_str_mv | AT petrillacole understandingdnadamageresponseanddnarepairinmultiplemyeloma AT gallowayjoshua understandingdnadamageresponseanddnarepairinmultiplemyeloma AT kudalkarruchi understandingdnadamageresponseanddnarepairinmultiplemyeloma AT ismaelaya understandingdnadamageresponseanddnarepairinmultiplemyeloma AT cottinifrancesca understandingdnadamageresponseanddnarepairinmultiplemyeloma |